Healthcare >> CEO Interviews >> February 4, 2002

David Gury – Nabi (nabi)

DAVID J. GURY was elected President, Chairman of the Board and Chief Executive Officer of Nabi Biopharmaceuticals in April 1992. In May 1984, Mr. Gury joined Nabi as President and Chief Operating Officer. Prior to joining Nabi Biopharmaceuticals, Mr. Gury spent his career with Abbott Laboratories in various administrative and executive positions and with Alpha Therapeutics Corporation, a spinout from Abbott. Mr. Gury completed his AB in Economics at Kenyon College, Gambier, Ohio, in 1960 and received his MBA at the University of Chicago in 1962, specializing in Accounting and Finance. His undergraduate junior year was spent at the University of Madrid, Spain. He was a Research Fellow at the University of Chicago and an intern with Arthur Andersen & Co. In addition to his duties at Nabi Biopharmaceuticals, Mr. Gury is a member of the Florida Emerging Technology Commission, Chairman of the Florida Research Consortium and past Chairman and a member of BioFlorida. Profile
TWST: Would you give us an update on the company? What has gone on over

the past year or so that investors should focus on?

Mr. Gury: In 2001, we had four major goals for the company. The